USE OF BETASERCA IN PATIENTS WITH HD WITH COCHLEOVESTIBULAR DISORDERS
U.S. KhasanovResearcher Tashkent Medical Academy, UzbekistanN.A. AkhunjhanovResearcher Tashkent Medical Academy, UzbekistanG.S. KhaydarovaResearcher Tashkent Medical Academy, UzbekistanK.E. ShaykhovaResearcher Tashkent Medical Academy, UzbekistanU.P. AbdullaevResearcher Tashkent Medical Academy, Uzbekistan
ABI
Abstract
Betahistine dihydrochloride is a synthetic drug that has the ability to bind to H1 histamine receptors, which are embedded in the neuroreceptor cells of the inner ear. It has a powerful stimulating effect by increasing the release of neurotransmitters (histamine) from the nerve endings of the inner ear receptor cells into the synapse. The neurotransmitter acts on the precapillary sphincters, causing vasodilation of the vessels of the inner ear, increasing their permeability and thereby normalizing intralabyrinthine pressure, i.e. eliminating hydrops.
Topics
Identifiers
Citations and references
Cited by 00 references